NSCLC cells that acquired an EMT phenotype under TGF-β exposure are resistant to cisplatin, but inhibition of Shh pathway is able to sensitize the cells to cisplatin and decrease the expression of CSC phenotype [115]. This evidence concerns the gene SHH and non-small cell lung carcinoma.